Conference Calendar - The 88th EAS Congress

All times are in CET (Central European Time)

Displaying One Session

View

CME Session

Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches

Session Type

CME Session

Chair(s)

Room

Hall 1

Date

07.10.2020, Wednesday

Session Time

17:30 - 19:00

Session Ticket

Session Evaluation

Option 1

Watch Stream
Session Webcast

Session Webcast

[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1751,"presentation":"Introduction","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"1751-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS201751.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS201751.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/38F8677A.jpg","data":[],"tracks":[]}]},{"name":"The biology of PCSK9","mode":"playlist","public":true,"info":{"id":1752,"presentation":"The biology of PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Bertrand Cariou, France","photo":""},"playlist":[{"name":"1752-The biology of PCSK9","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS201752.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS201752.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/7F581DAA.jpg","data":[],"tracks":[]}]},{"name":"Monoclonal antibody approaches targeting circulating PCSK9","mode":"playlist","public":true,"info":{"id":1753,"presentation":"Monoclonal antibody approaches targeting circulating PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Ulf Landmesser, Germany","photo":""},"playlist":[{"name":"1753-Monoclonal antibody approaches targeting circulating PCSK9","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS20_1753.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS20_1753.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/8CA46531.jpg","data":[],"tracks":[]}]},{"name":"siRNA based approaches targeting hepatic synthesis of PCSK9","mode":"playlist","public":true,"info":{"id":1754,"presentation":"siRNA based approaches targeting hepatic synthesis of PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/1332.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/Kausik Ray - EAS20 - 1754.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/Kausik Ray - EAS20 - 1754.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/32304323.jpg","data":[],"tracks":[]}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1755,"presentation":"Panel Discussion with Live Q&A","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey, Alberico Luigi Catapano, Italy, Bertrand Cariou, France, Ulf Landmesser, Germany, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/39D8742F.jpg","data":[],"tracks":[]}]}]